Government Reaffirms NonInterventionist Stance on Rupee Exchange Rates Says Minister Goyal Ferrari Launches First AllElectric Model Luce Stirring Debate and Market Competition US Treasury Yields Surge as RiskFree Asset Assumptions Shift Amid Geopolitical and Inflation Concerns Trumps Iran Priorities Keep Him From Family Event Underscoring Geopolitical Focus Mercury Fintech Firm Achieves 52 Billion Valuation After Latest Funding Round Trainline Raises FullYear Guidance for Second Time in 2026 TOL Q1 2026 Earnings Earnings Beat Expectations as Homebuilder Navigates Market Conditions Darling Ingredients DAR Q1 2026 Earnings EPS Smashes Estimates by 46 but Guidance Uncertainty Sinks Shares Slightly ROG Q1 2026 Earnings Strong EPS Beat Surprises Market TBH Q4 2025 Earnings Massive EPS Miss Highlights Operational Challenges QBTS Q1 2026 Earnings Strong EPS Beat Highlights Progress in Quantum Computing RCI Hospitality Holdings RICK Q3 2025 Earnings Significant EPS Miss Amid Operational Challenges Aptiv PLC APTV Surges 411 as Price Approaches Key Resistance Zone Research Solutions Inc RSSS Tests Key Support Zone After Modest Decline Art Technology Acquisition Warrants ARTCW Rally 606 to 035 Testing Key Resistance AiRWA Inc YYAI Holds Ground Near Support After Minor Dip reAlpha Tech Corp AIRE Faces Renewed Selling Pressure as Shares Drop Over 6 Technology Stocks Lead Mixed US Equity Markets on the 26th TRMB Q1 2026 Earnings EPS Beats Estimates by 794 Stock Slips on Market Sentiment CorMedix Inc CRMD Edges Lower as Stock Tests Key Support Near 758 NOK Q1 2026 Earnings EPS Surprises to the Upside Shares Rally ABCL Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction DUOL Q1 2026 Earnings EPS Beats Estimates by 164 Stock Edges Higher ZION Q1 2026 Earnings EPS Surprises to the Upside Amid Steady Banking Performance IAUX Q1 2026 Earnings Narrower Loss Beats Estimates as Gold Operations Gain Traction WORX Q3 2025 Earnings Net Loss Deepens as Stock Declines Sharply Firefly Neuroscience Inc AIFF Q3 1998 Earnings Steep Earnings Miss as PreRevenue Biotech Faces Cash Burn Headwinds